The Change of c-jun Promoter Activity in TPA-Induced U937 Cells Infected with Human Cytomegalovirus (HCMV).
- Author:
Chung Gyu PARK
1
;
Dae Joong KIM
;
Jin Hee KIM
;
Tae Hee HAN
;
Eung Soo HWANG
;
Myong Sik CHOI
;
Yoon Hoh KOOK
;
Sung Bae CHOI
;
Chang Yong CHA
Author Information
1. Department of Microbiology, College of Medicine and Institute of Endemic Diseases, Medical Research Center, Seoul National University, Seoul 110-799, Korea.
- Publication Type:In Vitro ; Original Article
- Keywords:
Human cytomegalovirus;
c-jun promoter;
Macrophage;
Permissiveness
- MeSH:
Binding Sites;
Cytomegalovirus*;
Fireflies;
Humans*;
Luciferases;
Macrophages;
Permissiveness;
Transfection;
U937 Cells*
- From:Journal of the Korean Society of Virology
1999;29(2):129-136
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Transient transfection assay has been done to evaluate whether the c-jun activation would be prerequisite to the induction of permissiveness against human cytomegalovirus using in vitro cell model in which U937 has been induced to express CD11b and CDl4 to become potential monocyte/macrophage cells by TPA treatment. U937 cells were treated with 10 microM, 50 microM or 100 microM of TPA. The cell morphology change was observed and the expression of the CD11b and CDl4 was confirmed by FACS. Differentiated cells were transfected with pJLuc reporter vector which contained the wild type murine c-jun promoter spanning the SP1, CTF, ATF/CREB and MEF-2 binding sites upstream of the firefly luciferase gene. After 48 hrs of transfection, the cells were infected with HCMV Towne strain and the luciferase activity was assessed at 1 h and 4 h pi. The transfection assay showed no activation of the c-jun promoter at 1 h pi, instead, it showed 2 times increase of the its activity at 4 h pi. There was no difference of the c-jun promoter activation between TPA treated and untreated U937 cells, implying that c-jun activation might not be prerequisite for allowing cells to be premissive to HCMV, although HCMV infection itself could activate c-jun promoter.
